• Logo
  • SBMUJournals

Validation of Worry Behaviors Inventory (WBI) among Normal Population

Sohrab Amiri, Vida Farzalizadeh, Yosef Jamali, Karim Babaei
119

Views

PDF

Abstract

Objective: This study aimed to evaluate the psychometric properties of Worry Behaviors Inventory (WBI) in normal population.Method: For this purpose, 286 participations (first study) and 40 participations (Second study) were selected in 2017. Then Worry Behaviors Inventory (WBI), Patient Health Questionnaire-9, WHODAS-II, HAQ, PHQ-15 and CABAH were distributed among them to respond. After collecting data, the reliability of the Inventory was assessed by using SPSS-22 and Lisrel 8.8, Cronbach's alpha, retest and split-half coefficient, then the Construct validity with other questionnaires to determine the psychometric properties of the Worry Behaviors Inventory (WBI). The Factor structure was assessed by confirmatory factor analysis.Results: The results of the factor analysis indicated that WBI has two factors and checking the reliability of the Inventory using Cronbach's alpha, test-retest and split-half coefficient reflects the stability of the scale, the Construct validity of the WBI with other questionnaires showed desirable discriminant and convergence validity.Conclusions: Overall, the findings indicated that WBI has good psychometric properties in normal population, and the tool can be used in studies in somatoform disorders. However, it seems that Worry Behaviors is the fundamental structure of somatoform disorders.     


Keywords

Somatoform disorders, Worry behavior inventory, Psychometric properties

References

-Hanel G, Henningsen P, Herzog W, Sauer N, Schaefert R, Szecsenyi J, et al. Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study. J Psychosom Res. 2009; 67,189-197.

-Toft T, Fink P, Oernboel E, Christensen K, Frostholm L, Olesen F .Mental disorders in primary care: prevalence and co-morbidity among disorders. Results from the functional illness in primary care (FIP) study. Psychol Med. 2005; 35,1175-1184.

-Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry. 2005; 62, 903-910.

-American Psychiatric Association. Somatic Symptom Disorders. http://www.dsm5. org/ProposedRevisions/Pages/proposedrevisio n.aspx?rid=368; 28-4-2012. Ref Type: Electronic Citation; 2012.

-Creed F, Guthrie E, Fink P, Henningsen P, Rief W, Sharpe M, et al. Is there a better term than“medically unexplained symptoms”? J Psychosom Res. 2010; 5, 8-68.

-Creed F. The relationship between somatic symptoms, health anxiety, and outcome in medical out-patients. Psychiatr Clin North Am. 2011; 34:545-64.

-Rief W, Hiller W, Margraf J. Cognitive aspects of hypochondriasis and the somatization syndrome. J Abnorm Psychol. 1998;107, 587595.

-Brown RJ. Psychological mechanisms of medically unexplained symptoms: an integrative conceptual model. Psychol Bull.2004; 130, 793-812.

-Kirmayer LJ, Taillefer S. Somatoform disorders. In S. M. Turner& , M. Hersen (Eds.), Adult psychopathology and diagnosis (3rd ed). (pp. 333e383). New York: Wiley; 1997.

-Gräfe K, Zipfel S, Herzog W, Löwe B. Screening psychischer Störungen mit dem “Gesundheitsfragebogen für Patienten (PHQD)”. Ergebnisse der deutschen Validierungsstudie. Diagnostica. 2004; 50: 171–81.

-Kroenke K, Spitzer RL, Williams JBW. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002; 64, 258-266.

-Zijlema WL, Stolk RP, Lowe B, Rief W, White PD, Rosmalen JG. How to assess common somatic symptoms in large-scale studies: a systematic review of questionnaires. J Psychosom Res. 2013; 74:459–68.

-Gierk B, Kohlmann S, Kroenke K, Spangenberg L, Zenger M, Brahler E, et al. The Somatic Symptom Scale-8 (SSS-8): a brief measure of somatic symptom burden. JAMA Intern Med March. 2004; 174: 399– 407.

-Gierk B, Kohlmann S, Toussaint A, Wahl I, Brunahl CA, Murray AM, et al. Assessing somatic symptom burden: a psychometric comparison of the Patient Health Questionnaire-15 (PHQ-15) and the Somatic Symptom Scale-8 (SSS-8). J Psychosom Res. 2015;78: 352–5.

-Kellner R. Abridged manual of the Illness Attitude Scales. Albuquerque: Department of Psychiatry, University of New Mexico; 1987.

-Rief W, Ihle D, Pilger F. A new approach to assess illness behaviour. J Psychosom Res. 2003; 405; 14-54.

-Klaus K, Mewes R. Assessment of the new DSM-5 Diagnosis Somatic Symptom Disorder (300.82). Verhaltenstherapie Verhaltensmedizin. 2013; 34:399–418.

-Pilowsky I. Dimensions of hypochondriasis. Br J Psychiatry. 1967; 113:89–93.

-Andrews G, Kemp A, Sunderland M, Von Korff M, Ustun TB. Normative data for the 12 item WHO Disability Assessment Schedule 2.0. PLoS One. 2009; 4, 8343.

-Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling A: Multidisciplinary Journal. 1999; 6, 1-55.

-Sirri L, Fava GA. Diagnostic criteria for psychosomatic research and somatic symptom disorders. Int Rev Psychiatry. 2013; 25(1):1930.

-Wittchen HU, Zaudig M, Fydrich T. Strukturiertes Klinisches Interview für DSMIV. Achse I: Psychische Störungen. SKID I. Göttingen: Hogrefe; 1997.

-Mahoney AEJ, Hobbs MJ, Newby JM, Williams AD, Sunderland M, Andrews G. The Worry Behaviors Inventory: Assessing the behavioral avoidance associated with generalized anxiety disorder. J Affect Disord. 2016; 203, 256–264.

-Kroenke K, Spitzer R, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16, 606– 613.

-Beard C, Hsu KJ, Rifkin LS, Busch AB, Björgvinsson T. Validation of the PHQ-9 in a psychiatric sample. J Affect Disord. 2016; 193, 267–273.

-Dum M, Pickren J, Sobell LC, Sobell MB. Comparing the BDI-II and the PHQ-9 with outpatient substance abusers. Addict Behav. 2008; 33, 381–387.

-Hepner KA, Hunter SB, Edelen MO, Zhou AJ, Watkins K. A comparison of two depressive symptomatology measures in residential substance abuse treatment clients. J Subst Abuse Treat. 2009; 37, 318–325.

-Kroenke K, Spitzer R, Williams JB, Löwe B. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales. Gen Hospital Psychiatry. 2010; 32, 345–359.

-Rehm J, Üstün BT, Saxena S, Nelson CB, Chatterji S, Ivis F, Adlaf ED. On the development and psychometric testing of the WHO screening instrument to assess disablement in the general population. Int J Methods Psychiatr Res. 1998; 8, 110–122.

-Üstün TB, Kostanjsek N, Chatterji S, Rehm JE. Measuring Health and Disability: Manual for WHO Disability Assessment Schedule. World Health Organisation, Malta; 2010.

-Lucock MP, Morley S. The health anxiety questionnaire. Br J Health Psychol. 1996; 1(2):137–150.

-Hiller W, Rief W, Elefant S, Margraf J, Kroymann R, Leibbrand R, et al. Dysfunktionale Kognitionen bei Patienten mit Somatisierungssyndrom. Z Klin Psychol. 1997; 26: 226–34.

-Jöreskog KG, Sörbom D. LISREL 8.80 for Windows [Computer Software]. Lincolnwood, IL: Scientific Software International, Inc; 2006.

- George, D., & Mallery, P. (2003). SPSS for Windows step by step: a simple guide and reference. 11. 0 update (4th ed.). Boston, MA: Allyn & Bacon.

-Brown T A. Confirmatory factor analysis for applied research. New York: Guilford Press; 2006.

-Schermelleh-Engel K, Moosbrugger H, Müller H. Evaluating the fit of structural equation models: Tests of significance and descriptive goodness of fit measures. Psycholo Res. 2003; 8, 23-74.

-Tabachnick BG, Fidell LS. Using multivariate statistics. Allyn and Bacon; 2007.




DOI: https://doi.org/10.22037/ijabs.v4i3.20392

Refbacks

  • There are currently no refbacks.